Skip to main content

Military Health System

Important Notice about Pharmacy Operations

Change Healthcare Cyberattack Impact on MHS Pharmacy Operations. Read the statement to learn more. 

Naval Medical Research Center Uses Genome Sequencing for Variants

Image of Military personnel pose for a group photo. FREDERICK, Md. (Oct. 11, 2022) Naval Medical Research personnel with the Biological Defense Research Directorate’s Genomics and Bioinformatics department pose for a group photo. BDRD, located at Fort Detrick, works to advance research and development of therapeutics to protect against biological attacks. The effort is part of the DOD SARS-CoV-2 Whole Genome Sequencing Action Plan, which brings together laboratories to conduct whole genome sequencing across the Military Health System in response to the COVID-19 pandemic.

Editor's note: This is the fifth article in a 7-part series that highlights the work of technicians and scientists in Military Health System laboratories who worked to identify COVID-19 variants using special sequencing technology.

The Naval Medical Research Command's Biological Defense Research Directorate has sequenced over 6,700 samples and provided support to key shipboard and military training populations to identify COVID-19 variants. Specific fleet assets supported with viral genome sequencing by NMRC include the USS Theodore Roosevelt and eight other ships. It also includes military treatment facilities, the fleet, and the U.S. Army, U.S. Air Force, U.S. Navy, and U.S. Marine Corps units, with samples originating within the United States and from four continents.

"Being able to provide detailed information regarding the variants allows for up-to-date information to the fleet and Marine force, as well as other services,” said U.S. Navy Capt. William Deniston, commander of Naval Medical Research Center. "This information helps inform leadership on the most current threats to the armed forces."

The data provided on samples from Camp Lemonnier, a U.S. naval base in Djibouti, Africa, helped provide important information for stakeholders in U.S. Africa Command and the West African region, by providing surveillance of circulating variants in U.S. forces in an under-sampled region. The SARS-CoV-2 genome sequences produced at NMRC were the first published viral sequences from Djibouti and resulted in identification of rare mutations.

Headquartered at Fort Detrick, Maryland, the NMRC-BDRD also played an instrumental role in the COVID-19 outbreak response, coordinating SARS-CoV-2 sample receiving and sharing among labs in the National Capital Region. NMRC’s efforts provided important support for sequencing and viral isolation to the Department of Defense and Military Health System, as well as training to partner laboratories on SARS-CoV-2 protocols and bioinformatics analysis.

"NMRC's BDRD is uniquely qualified to conduct the deep sequencing needed to do this work. The incredible scientists we have at NMRC are the best in the business," stated Deniston.

You also may be interested in...

Publication
Aug 1, 2022

Whole Health System Approach to Long COVID

The U.S. Department of Veterans Affairs Veterans Health Administration is leading an effort to equip health care providers with a Veteran-centered Whole Health System approach to caring for Veterans with Long COVID, also known as post-COVID-19 conditions.

Publication
Oct 21, 2020

Updated Guidance for Performing Temperature Checks at Military MTFs and DTFs

.PDF | 179.18 KB

This guidance is an update to Defense Health Agency Return to Full Operations Concept of Operations, V5.0 (June 12, 2020) as it pertains to temperature checks in MTFs and DTFs. Based on recommendations from the Centers for Disease Control (CDC), previous guidance directed MTFs to take the temperature of all individuals entering the facility. ...

Publication
Aug 6, 2020

Force Health Protection Guidance (Supplement 12) -Department of Defense Guidance for Personnel Traveling During the Coronavirus Disease 2019 Pandemic

.PDF | 4.56 MB

This memorandum supplements requirements in references (a), (b), and (c) with respect to coronavirus disease 2019 (COVID-19), and replaces reference (d). It provides pre- and post­travel guidance for purposes of force health protection (FHP) of Service members, DoD family members, DoD civilian employees, and DoD contractor personnel.

Publication
Jun 3, 2020

Communication to ABA Providers Regarding Continued Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

.PDF | 122.59 KB

TRICARE is announcing the continuation of the temporary exception to policy regarding the use of synchronous telehealth (TH) capabilities (both audio and video) for Applied Behavior Analysis (ABA) Family Adaptive Behavior Treatment Guidance services specifically during this COVID-19 pandemic.

Publication
May 26, 2020

Force Health Protection Guidance (Supplement 9) -Department of Defense Guidance for Deployment and Redeployment of Individuals and Units during the Novel Coronavirus Disease 2019 Pandemic

.PDF | 243.02 KB

This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).

Publication
Apr 20, 2020

Modification and Reissuance of DoD Response to Coronavirus Disease 2019 -Travel Restrictions

.PDF | 960.08 KB

All DoD Service members will stop movement, both internationally and domestically, while this memorandum is in effect. All DoD civilian personnel, and dependents of DoD Service members and DoD civilian personnel, whose travel is Government-funded will stop movement, both internationally and domestically, while this memorandum is in effect.

Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery